| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to a percutaneously absorbable preparation comprising 2-[(1-benzylpiperidin-4-yl)methyl]-5,6~dimethoxyindan-1-one and/or its hydrochloride in a pressure-sensitive adhesive layer, wherein the percutaneously absorbable preparation may be administered into a patient so that Cmax per a surface area unit of the percutaneously absorbable preparation is 0.025 to 0.5 ng/ml·cmin the plasma concentration profile. The preparation has a favourable plasma concentration profile of 2-[(1-benzylpiperidin-4-yl)methyl]-5,6~dimethoxyindan-1-one and/or its hydrochloride with no jump of the plasma concentration.EFFECT: what is presented is the percutaneously absorbable preparation.29 cl, 1 tbl, 2 dwg, 4 ex |
